1831P Role of body composition (bc) in advanced non-small cell lung cancer (NSCLC) patients receiving first-line pembrolizumab (pembro)

Authors :: Marco Cintoni
Daniela Tregnago
D. Kadrija
Alice Avancini
Ilaria Trestini
Mirko D'Onofrio
Alessandra Dodi
M.C. Mele
Luisa Carbognin
M. Sposito
M. Milella
Miriam Casali
E. Bria
Giulia Sartori
Lorenzo Belluomini
Fiorella Lombardo
A. Drudi
Sara Pilotto
Isabella Sperduti
G. Aluffi
Source :: Annals of Oncology. 31:S1054
Publication Year :: 2020
Publisher :: Elsevier BV, 2020.

Subjects :: Oncology
medicine.medical_specialty
business.industry
First line
Internal medicine
medicine
non-small cell lung cancer (NSCLC)
Hematology
Pembrolizumab
medicine.disease
business

Full Text Access

Tools